Mammoth Biosciences
CRISPR diagnostics and gene-editing platform co-founded by Nobel laureate Jennifer Doudna
Biotech
📍 Brisbane, CA
Founded 2018
Current Valuation
$1.0B
as of 2021-Q3
UNICORN
Mammoth was co-founded by CRISPR Nobel laureate Jennifer Doudna and discovered the Cas14 and CasΦ ultra-compact CRISPR systems suitable for in-vivo gene therapy. Pivoted from molecular diagnostics into CRISPR-based therapeutics. Partnership with Bayer for in-vivo gene editing applications.
Company Profile
Last Round
Series D — $195M (Sep 2021) · Lead: Redmile Group
IPO Status
no imminent plans
Founders & Key People
Trevor MartinJennifer DoudnaLucas HarringtonJanice Chen
Investors
Redmile Group · Foresite Capital · Senator Investment Group · Decheng Capital · Mayfield
Products
- DETECTR (CRISPR diagnostics)
- Ultra-Compact CRISPR enzymes (Cas14, CasΦ)
Competitors
Caribou Biosciences · CRISPR Therapeutics · Intellia · Editas Medicine
BiotechCRISPRGene EditingDoudna
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q3. Refreshed quarterly.